neutral
5 days agoCorona Remedies IPO draws strong investor demand as Day 3 bidding progresses
Investor interest in Corona Remedies Ltd remained firm as the pharmaceutical company’s IPO entered its final day of bidding on December 10. By the end of Day 2, the issue was subscribed 9.33 times, receiving bids for over 4.26 crore shares against 45.71 lakh shares on offer. Non-institutional investors led demand with 26.80 times subscription, while retail participation stood at 6.37 times.
neutral
5 days agoCorona Remedies IPO draws strong investor demand as Day 3 bidding progresses
Investor interest in Corona Remedies Ltd remained firm as the pharmaceutical company’s IPO entered its final day of bidding on December 10. By the end of Day 2, the issue was subscribed 9.33 times, receiving bids for over 4.26 crore shares against 45.71 lakh shares on offer. Non-institutional investors led demand with 26.80 times subscription, while retail participation stood at 6.37 times.
1 min read
62 words
Strong demand continued for Corona Remedies IPO on Day 3 as the issue remained over nine times subscribed, driven primarily by heavy interest from non-institutional investors.
Investor interest in Corona Remedies Ltd remained firm as the pharmaceutical company’s IPO entered its final day of bidding on December 10. By the end of Day 2, the issue was subscribed 9.33 times, receiving bids for over 4.26 crore shares against 45.71 lakh shares on offer. Non-institutional investors led demand with 26.80 times subscription, while retail participation stood at 6.37 times.
Investor interest in Corona Remedies Ltd remained firm as the pharmaceutical company’s IPO entered its final day of bidding on December 10. By the end of Day 2, the issue was subscribed 9.33 times, receiving bids for over 4.26 crore shares against 45.71 lakh shares on offer. Non-institutional investors led demand with 26.80 times subscription, while retail participation stood at 6.37 times.
Dec 10, 2025 • 05:40